Zimmer Biomet’s CEO, Ivan Tornos, earned $15 million in total compensation in 2024, according to a recent Securities and ...

Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $112.503 0.58% Open 111.5 Day High 113.6 52 Week High 133.6 52 Week ...

Zimmer Biomet Holdings, Inc. (ZBH) is a leading global medical device company specializing in orthopedic solutions. With a market cap of $22 billion, Zimmer Biomet operates in over 25 countries and ...

BTIG analysts maintained their Buy rating on Zimmer Biomet (NYSE:ZBH) with a price target of $126.00 after the company announced its plans to acquire Paragon 28. The deal, valued at approximately $1.2 ...

Zimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report). The company’s shares closed yesterday at $104.03.

WARSAW, Ind., and ZUG, Switzerland, April 1, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today ...

Raymond James Financial Inc. bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC.

Zimmer Biomet Holdings, Inc. has a 12 month low of $97.69 and a 12 month high of $131.61. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.91 and a quick ratio of 0.99.

March 10, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting its diverse portfolio of orthopedic and ...